Sharon E Murphy Selected Research

Trimethylaminuria

2/2013

Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon E Murphy Research Topics

Disease

25	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2003
11	Neoplasms (Cancer) 10/2020 - 02/2003
5	Tobacco Use Disorder (Nicotine Dependence) 11/2021 - 11/2008
4	Inflammation (Inflammations) 01/2020 - 07/2016
4	Carcinogenesis 03/2016 - 02/2003
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 01/2011
1	Asthma (Bronchial Asthma) 01/2022
1	Mental Disorders (Mental Disorder) 12/2019
1	Psychotic Disorders (Schizoaffective Disorder) 12/2019
1	Schizophrenia (Dementia Praecox) 12/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2019
1	Wounds and Injuries (Trauma) 11/2013
1	Trimethylaminuria 02/2013
1	Adenoma (Adenomas) 11/2011
1	Carcinoma (Carcinomatosis) 11/2011
1	Heart Diseases (Heart Disease) 03/2008
1	Lung Diseases (Lung Disease) 12/2005
1	Esophageal Neoplasms (Esophageal Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2005
19	Nicotine FDA Link 01/2022 - 03/2008
15	CarcinogensIBA 10/2020 - 02/2003
11	SmokeIBA 10/2020 - 12/2003
10	CotinineIBA 01/2020 - 03/2008
5	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 12/2019 - 03/2008
5	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 03/2016 - 05/2006
4	NitrosaminesIBA 04/2009 - 02/2003
3	Dinoprostone (PGE2)FDA Link 01/2019 - 07/2016
2	DNA AdductsIBA 10/2020 - 03/2016
2	ORALIT (ORS)IBA 01/2020 - 11/2011
2	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 01/2019 - 01/2019
2	EicosanoidsIBA 01/2019 - 01/2019
2	AcidsIBA 01/2019 - 01/2019
2	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2019 - 03/2008
2	hydroxycotinineIBA 01/2017 - 03/2016
2	EnzymesIBA 01/2017 - 07/2011
2	phenethyl isothiocyanate (PEITC)IBA 07/2016 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2016 - 07/2011
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 02/2014 - 11/2011
2	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 02/2013 - 07/2011
2	GlucuronidesIBA 11/2011 - 03/2008
2	N-NitrosopyrrolidineIBA 01/2005 - 02/2003
2	4-nitrophenyl myo-inositol-1-phosphateIBA 10/2003 - 02/2003
1	Biological ProductsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	CreatinineIBA 01/2017
1	IsothiocyanatesIBA 07/2016
1	7,8-dihydromethysticinIBA 03/2016
1	1,3-butadiene (divinyl)IBA 11/2014
1	hydroxide ionIBA 02/2014
1	Volatile Organic CompoundsIBA 02/2014
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 06/2013
1	trimethylamineIBA 02/2013
1	r- 1,t- 2,3,c- 4- tetrahydroxy- 1,2,3,4- tetrahydrophenanthreneIBA 11/2011
1	Uridine Diphosphate (UDP)IBA 07/2011
1	TransferasesIBA 07/2011
1	4,6-dinitro-o-cresol (DNOC)IBA 07/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2011
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2008
1	1-hydroxypyreneIBA 03/2008
1	Fibrinogen (Factor I)FDA Link 03/2008
1	C-Reactive ProteinIBA 03/2008
1	Carbon MonoxideIBA 03/2008
1	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 12/2003
1	N-nitrosopiperidineIBA 02/2003

Therapy/Procedure

2	Chemoprevention 10/2020 - 02/2008
1	Tobacco Use Cessation Devices 02/2010